Table 3.
Variables | Group 1 n=27 | Group 2 n=4 | Group 3 n=50 | P Value |
---|---|---|---|---|
Age | 73.0±7.4 | 76.3±4.3 | 72.4±8.4 | 0.64 |
Male sex, n (%) | 19 (70) | 3 (75) | 39 (78) | 0.82 |
Aneurymal diameter (maximum) (mm) | 55.9±9.2 | 58.0±9.4 | 53.1±7.3 | 0.22 |
Expansion rate (mm/year) | 7.45±5.13 | 3.66±2.47 | 4.17±2.67 | 0.002 |
Comorbidities, n (%) | ||||
Hypertension | 22 (81) | 3 (75) | 44 (88) | 0.46 |
Ischemic heart disease | 9 (33) | 0 (0) | 15 (30) | 0.51 |
Cerebrovascular disease | 1 (4) | 1 (25) | 5 (10) | 0.21 |
Diabetes mellitus | 5 (19) | 0 (0) | 7 (14) | 0.87 |
Smoking (ex‐ or current) | 20 (74) | 4 (100) | 35 (70) | 0.64 |
Medication, n (%) | ||||
Aspirin use | 6 (22) | 1 (25) | 15 (30) | 0.83 |
Statin use | 12 (44) | 1 (25) | 16 (32) | 0.52 |